文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Wojciech Jurczak
发表
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
Nibedita Bandyopadhyay, Martin Dreyling, Mathias Witzens-Harig, 2016, The Lancet.